Rapamycin inhibits doxorubicin-induced NF-κB/Rel nuclear activity and enhances the apoptosis of melanoma cells
- 1 December 2004
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 40 (18), 2829-2836
- https://doi.org/10.1016/j.ejca.2004.08.017
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- Inhibition of IκB Kinase by a New Class of Retinoid-Related Anticancer Agents That Induce ApoptosisMolecular and Cellular Biology, 2003
- Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4EGenes & Development, 2002
- Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancerOncogene, 2001
- Insulin produces myogenesis in C2C12 myoblasts by induction of NF-?B and downregulation of AP-1 activitiesJournal of Cellular Physiology, 2000
- IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell SurvivalScience, 1998
- Identification and Characterization of an IκB KinaseCell, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989